)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
Fulgent Genetics
Fulgent Genetics (FLGT) investor relations material
Fulgent Genetics Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary27 Feb, 2026
Executive summary
Achieved full-year 2025 revenue of $322.7 million, up 14% year-over-year, with Q4 revenue at $83.3 million, a 9% increase year-over-year.
Laboratory services, especially precision diagnostics and anatomic pathology, were key revenue drivers, supported by investments in AI and digital pathology.
Therapeutic pipeline advanced: FID-007 completed Phase II enrollment and FID-022 progressed through Phase I.
Announced acquisition of Bako Diagnostics and StrataDx for $55.5–$56 million, expected to close in March 2026, expanding anatomic pathology services.
Proprietary technology and AI/ML analytics enabled rapid test development and operational efficiency.
Financial highlights
Q4 2025 gross margin was 41% non-GAAP and 39.1% GAAP; full-year gross margin was 42.7% non-GAAP and 40.6% GAAP.
Q4 GAAP loss was $23.4 million; adjusted EBITDA loss was $4.5 million.
Full-year non-GAAP income was $13.2 million, or $0.42 per share; Q4 non-GAAP EPS was $0.16.
Ended 2025 with $705.5 million in cash, cash equivalents, restricted cash, and marketable securities.
Operating cash flow was $(102) million, impacted by a delayed $106 million federal tax refund.
Outlook and guidance
2026 revenue guidance is $350 million, up 8–8.5% year-over-year, with Bako and StrataDx expected to contribute $50–$56 million.
Non-GAAP EPS guidance for 2026 is a loss of $1.45 per share.
Anticipated 2026 year-end cash position of $685 million, assuming receipt of delayed $106 million tax refund and factoring in acquisitions.
Non-GAAP gross margins expected slightly above 40% for 2026, with lower margins in H1 due to revenue mix.
Non-GAAP operating margin projected to decrease to between -8% and -18% for 2026.
Net revenue impact of customer loss vs. acquisitions?
2026 therapeutic pipeline key milestones?
What is the status of the $106M tax refund?
2026 customer concentration profile
Bako/StrataDx digital pathology integration
Key milestones for therapeutic pipeline
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next Fulgent Genetics earnings date
Q1 20261 May, 2026
Fulgent Genetics
Next Fulgent Genetics earnings date
Q1 20261 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Fulgent Genetics, Inc. provides clinical genetic testing services in the United States and internationally. It offers genetic testing services for various types of heredity conditions, such as intellectual disability and movement disorders; infectious diseases, including sexually transmitted infections; pharmacogenetic tests to help individuals determine drug sensitivities; oncology testing services focused on inherited cancer predisposition; prenatal genetic testing for genetic abnormalities; and pediatric and adult behavioral tests for attention deficit hyperactivity disorders. The company also provides COVID-19 testing kits to physicians. In addition, it offers development of customized multi-gene panels for clinical trial recruitment, which are designed for specific panels of genes associated with various genotypes or phenotypes; and PathFinderTG tool that evaluates the likelihood that a patient's symptoms could be caused by an underlying genetic condition. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage